Simplify Life with Omnipod® 5
The first and only tubeless automated insulin delivery system that works with the leading sensor brands*
Omnipod 5 is the first wearable, tubeless, hybrid closed loop insulin delivery system to integrate with the Dexcom G6 sensor and the FreeStyle Libre 2 Plus sensor**.
Omnipod 5 automatically adjusts insulin delivery every 5 minutes, helping to protect against highs and lows1,2. It’s the system that never sleeps.
What is Pod Therapy?
Pod Therapy is simple, tubeless, discreet insulin pump therapy for people living with type 1 diabetes, ages 2 and older.
Each wearable Pod continuously delivers personalised doses of insulin for up to three days (72 hours), controlled wirelessly by you, wherever you are.
With no multiple daily injections and no tubes, Pod Therapy is insulin pump therapy, simplified. Only found with Omnipod®.
Meet our tubeless, wearable Omnipod® lineup
Omnipod 5 Automated Insulin Delivery System
Now available with a choice of glucose sensor! Omnipod 5 automatically adjusts your insulin every five minutes, helping to stay in range throughout the day and night.
Omnipod DASH® Insulin Management System
You’re in control with the Omnipod DASH® Personal Diabetes Manager. Discover discreet, precise insulin dosing and customisable programmes designed to fit around your lifestyle.
Sign up to a live demo
Considering Pod Therapy with Omnipod?
Sign up to one of our free virtual live demos with an Omnipod representative to find out more about how Omnipod DASH and Omnipod 5 work, and how they could help to manage you or your child’s diabetes.
We believe in Freedom of Choice!
At Insulet, we believe those who have been deemed eligible for pump therapy should have the freedom to choose and the flexibility to change insulin delivery devices with no ‘lock-in’ periods.
Are you new to pump therapy, or considering switching to a different insulin pump? Find out more about how our commitment to choice may help you.
Here’s what our Podders® have to say about Omnipod 5…
Omnipod® 5 has allowed me to get a good night sleep. That's the first time I can say that in a long time.
Alvin
Podder since 2017
It helps me feel like a normal kid, just with a little bit of help.
Romey T.
Sponsored Omnipod® User
& Podder since 2019
I don’t have to spend as much time thinking about diabetes.
Clare F.
Podder® since 2013
Try it on for size
Request a free Pod Experience Kit today and try a demo Pod# for yourself!
Whether you’re considering Omnipod 5 or Omnipod DASH, our real-size, real-weight demo Pod# can help you understand what it feels like to wear the Pod, and get a sense of how discreet it can be.
Talk to an Omnipod® Specialist
Still have more questions about the Omnipod® System? Enter your information below and one of our Omnipod® Specialists will call you in 24-48 hours for a one-to-one chat. Or you can call us direct at 0800 011 6132* (option 4) or +44 20 3887 1709 (option 4) if calling from abroad.
Already a Podder®?
Find everything you need in one place, in your personal user portal.
Update contact and delivery details
Log Adhesive and hazard alarm issues
Confirm and track your orders
Check our hints and tips
**A separate prescription is required for the sensor. The Dexcom G6 and FreeStyle Libre 2 Plus sensors are sold separately.
† The Pod has an IP28 rating for up to 7.6 metres (25 feet) for 60 minutes. The Omnipod 5 Controller is not waterproof. Please see sensor manufacturer user guide for sensor waterproof rating‡ Fingerpricks required for diabetes treatment decisions if symptoms or expectations do not match readings.
1. Study in 240 people with T1D aged 6 - 70 years involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average time with high blood glucose in adults/adolescents and children, standard therapy vs. 3-month Omnipod 5: 32.4% vs. 24.7%; 45.3% vs. 30.2%. Median time with low blood glucose in adults/adolescents and children, standard therapy vs. 3-mo Omnipod 5: 2.0% vs. 1.1%; 1.4% vs. 1.5%. Brown et al. Diabetes Care (2021)
2. Study in 80 people with T1D aged 2 - 5.9 yrs involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average time with high blood glucose (>180mg/dL) from CGM in standard therapy vs Omnipod 5 = 39.4% vs. 29.5%. Average time with low blood glucose (<70mg/dL) from CGM in standard therapy vs Omnipod 5 = 3.41% vs. 2.13%. Sherr JL, et al. Diabetes Care (2022).